IDH1 and astrocytoma (excluding glioblastoma): In the 19 IDH-mt astrocytoma cases, TP53 (95%), ATRX (63%), MLL2 (21%), and CDKN2A/B homozygous deletion (16%) were detected (Figure 2B).